Vera Therapeutics, Inc. (VERA)

NASDAQ: VERA · Real-Time Price · USD

Compare

30.09

-0.44 (-1.44%)

At close: Oct 10, 2025, 4:00 PM EDT

29.20

-0.89 (-2.96%)

After-hours: Oct 10, 2025, 6:07 PM EDT

Vera Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-218.28	-152.15	-95.99	-89.06	-32.61	-53.41
Depreciation & Amortization	2.23	2.17	2.25	1.43	0.18	0.25
Stock-Based Compensation	29.02	20.8	11.49	8.89	3.01	0.33
Other Adjustments	-8.12	-8.16	-4.11	4.4	2.2	17.9
Changes in Accounts Payable	8.49	-3.45	-0.87	10.61	0.48	0.57
Changes in Accrued Expenses	7.62	7.19	-2.22	7.04	5.39	0.11
Changes in Other Operating Activities	-7.03	-1.08	-2.73	-10.9	-2.36	-0.55
Operating Cash Flow	-185.27	-134.68	-92.18	-67.6	-23.71	-34.81
Capital Expenditures	-1.28	-0.97	-0.06	-0.06	-	-0.1
Sale of Property, Plant & Equipment	-	-	-	-	-	0.06
Purchases of Intangible Assets	-	-	-	-	-5	-
Proceeds from Sale of Intangible Assets	-	-	-	-	0.8	-
Purchases of Investments	-554.21	-703.02	-224.93	-148.49	-	-
Proceeds from Sale of Investments	417.08	278.96	185.56	78	-	-
Investing Cash Flow	-139.21	-425.03	-39.43	-70.55	-4.2	-0.04
Long-Term Debt Issued	-	-	24.74	19.82	4.92	5.6
Long-Term Debt Repaid	-	-	-	-	-	-0.13
Net Long-Term Debt Issued (Repaid)	-	-	24.74	19.82	4.92	5.47
Issuance of Common Stock	5.06	645.91	116.06	88.21	51.73	0.23
Repurchase of Common Stock	-	-0.01	-	-	-	-
Net Common Stock Issued (Repurchased)	5.06	645.9	116.06	88.21	51.73	0.23
Issuance of Preferred Stock	-	-	-	-	-	80
Net Preferred Stock Issued (Repurchased)	-	-	-	-	-	80
Other Financing Activities	-	-39.23	-7.26	-6.1	-2.77	-0.41
Financing Cash Flow	348.51	606.67	133.54	101.93	53.88	85.29
Net Cash Flow	24.04	46.97	1.93	-36.22	25.97	50.44
Beginning Cash & Cash Equivalents	25.09	45.68	43.75	79.97	54	3.56
Ending Cash & Cash Equivalents	49.12	92.65	45.68	43.75	79.97	54
Free Cash Flow	-186.55	-135.65	-92.24	-67.66	-23.71	-34.91
Free Cash Flow Per Share	-3.07	-2.45	-2.16	-2.55	-1.76	-109.10
Levered Free Cash Flow	-208.25	-148.29	-74.89	-61.13	-24	-47.67
Unlevered Free Cash Flow	-226.02	-163.31	-105.65	-82.79	-30.72	-51.97

Updated Aug 5, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q